Incorporating the Pharmacist into the Rheumatology Practice
Originally published in Rheumatology Network Better treatment outcomes have been documented in studies when physicians and pharmacists work together. During last year’s American College of Rheumatology’s annual meeting, Irvin Huang of the Boise VA Medical Center in Idaho, presented a small study of a pharmacist-managed titration program in which gout patients achieved significantly lower serum uric acid […]
ACR’s Recommendations for Controlling Drug Costs, Improving Outcomes
Originally published in Rheumatology Network Affordability is a leading cause of drug abandonment among rheumatology patients. Out-of-pocket costs can be substantial. For example, rheumatoid arthritis patients pay $5,471 in annual out-of-pocket costs for Humira, according to a report issued by the Kaiser Family Foundation in February. Back in April, the American College of Rheumatology issued a […]
We’re Exhibiting at National Organization of Rheumatology Managers
ARN’s CEO Ray Waldrup is looking forward to exhibiting at the NORM 2019 conference in a couple of days! Stop by Booth 3 for more information about how ARN GPO connects independent rheumatology practices across the nation to support one another in best practices, improve patient access and physician autonomy through value-based treatment pathways and […]
How One Rheumatology Practice Bolstered Uptake Of Biosimilar Infliximab
Originally published in Biosimilar Development by Anna Rose Welch, Editor It never ceases to excite me when I hear that some organization, hospital, or clinic has found a way to bring biosimilars to its patients — regardless of all the noise happening in the industry today. Though I imagine there are more patients being treated […]
“Not So Different”: How a Value-Based Pathway Led to Increased Biosimilar Use
Originally published in the The Center For Biosimilars Web Site It’s no secret that biosimilars that treat inflammatory diseases have struggled to gain ground in the United States, with few products launched relative to those approved, low uptake of the products that are available, and formulary restrictions that sometimes favor branded biologics over biosimilar options. […]
Why This Biosimilar Initiative In Rheumatology Is One To Watch
Originally published in Biosimilar Development by Anna Rose Welch, Editor Generally speaking, when it comes to fixing or advancing the U.S. healthcare system, it’s easier said than done. Look no further than the endless slew of proposed legislation that has, more often than not, been struck down in recent months. While in the EU, it’s […]
TSI Healthcare Hosts Inaugural Rheumatology User Group Meeting
TSI Healthcare, the national leader in the sales and support of customized rheumatology specific solutions, hosted its inaugural Rheumatology User Group Meeting August 2-3, 2019 in its home state of North Carolina. This meeting was the first of its kind for independent rheumatologists and other rheumatology professionals. CHAPEL HILL, N.C., August 15, 2019 /PRNewswire-PRWeb/ — TSI Healthcare, […]
Using Value-Based RA Pathway Leads to a Shift to Biosimilars for AHG
Originally published in The Center for Biosimilars Biosimilars have struggled to gain ground in the United States, with few products launched, relatively low uptake of commercially available products, formulary restrictions that sometimes favor branded biologics over biosimilar options, and exclusionary contracting practices that block biosimilars from formularies altogether. A variety of policy proposals have been put forward to help […]
Rheumatologists Lead Biosimilar Uptake with Value-Based Pathways
By Colin C. Edgerton, M.D. Biosimilar Adoption Falters Rheumatologists hoped that biosimilars would reduce the costs of treating diseases such as rheumatoid arthritis (RA), and thereby increase access to these life altering medications for our patients. The recent Forbes article, “Biosimilars Continue to Exhibit Market Failure” confirms what we as rheumatologists are observing, that biosimilars […]
Recipients of Award to Assist with Workforce Expansion in Rheumatology
The field of rheumatology is experiencing a workforce shortage that is expected to worsen in years to come, and many patients living with rheumatic disease already live in medically underserved areas across the nation. Articularis Healthcare is proud to offer care with 12 locations across two states, spanning 11 counties. It’s not uncommon for patients […]